List of Tables
Table 1. Human Coagulation Factor VIII CAGR in Value, India VS Global, 2018 VS 2022 VS 2029
Table 2. Human Coagulation Factor VIII Market Trends
Table 3. Human Coagulation Factor VIII Market Drivers
Table 4. Human Coagulation Factor VIII Market Challenges
Table 5. Human Coagulation Factor VIII Market Restraints
Table 6. Global Human Coagulation Factor VIII Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. India Human Coagulation Factor VIII Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Human Coagulation Factor VIII Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 9. India Human Coagulation Factor VIII Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 10. Global Key Manufacturers of Human Coagulation Factor VIII, Ranked by Revenue (2022) & (US$ Million)
Table 11. Global Human Coagulation Factor VIII Revenue by Manufacturer, (US$ Million), 2018-2023
Table 12. Global Human Coagulation Factor VIII Revenue Share by Manufacturer, 2018-2023
Table 13. Global Human Coagulation Factor VIII Sales by Manufacturer, (K Bottles), 2018-2023
Table 14. Global Human Coagulation Factor VIII Sales Share by Manufacturer, 2018-2023
Table 15. Global Human Coagulation Factor VIII Price by Manufacturer (2018-2023) & (USD/Bottle)
Table 16. Global Human Coagulation Factor VIII Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Human Coagulation Factor VIII by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Coagulation Factor VIII as of 2022)
Table 18. Global Key Manufacturers of Human Coagulation Factor VIII, Manufacturing Base Distribution and Headquarters
Table 19. Global Key Manufacturers of Human Coagulation Factor VIII, Product Offered and Application
Table 20. Global Key Manufacturers of Human Coagulation Factor VIII, Date of Enter into This Industry
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Key Players of Human Coagulation Factor VIII in India, Ranked by Revenue (2022) & (US$ million)
Table 23. India Human Coagulation Factor VIII Revenue by Players, (US$ Million), (2018-2023)
Table 24. India Human Coagulation Factor VIII Revenue Share by Players, (2018-2023)
Table 25. India Human Coagulation Factor VIII Sales by Players, (K Bottles), (2018-2023)
Table 26. India Human Coagulation Factor VIII Sales Share by Players, (2018-2023)
Table 27. Global Human Coagulation Factor VIII Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 28. Global Human Coagulation Factor VIII Sales in Volume by Region (2018-2023) & (K Bottles)
Table 29. Global Human Coagulation Factor VIII Sales in Volume Forecast by Region (2024-2029) & (K Bottles)
Table 30. Global Human Coagulation Factor VIII Sales in Value by Region (2018-2023) & (US$ Million)
Table 31. Global Human Coagulation Factor VIII Sales in Value Forecast by Region (2024-2029) & (US$ Million)
Table 32. Americas Human Coagulation Factor VIII Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. Americas Human Coagulation Factor VIII Sales in Value by Country (2018-2023) & (US$ Million)
Table 34. Americas Human Coagulation Factor VIII Sales in Value by Country (2024-2029) & (US$ Million)
Table 35. Americas Human Coagulation Factor VIII Sales in Volume by Country (2018-2023) & (K Bottles)
Table 36. Americas Human Coagulation Factor VIII Sales in Volume by Country (2024-2029) & (K Bottles)
Table 37. EMEA Human Coagulation Factor VIII Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. EMEA Human Coagulation Factor VIII Sales in Value by Country (2018-2023) & (US$ Million)
Table 39. EMEA Human Coagulation Factor VIII Sales in Value by Country (2024-2029) & (US$ Million)
Table 40. EMEA Human Coagulation Factor VIII Sales in Volume by Country (2018-2023) & (K Bottles)
Table 41. EMEA Human Coagulation Factor VIII Sales in Volume by Country (2024-2029) & (K Bottles)
Table 42. APAC Human Coagulation Factor VIII Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. APAC Human Coagulation Factor VIII Sales in Value by Country (2018-2023) & (US$ Million)
Table 44. APAC Human Coagulation Factor VIII Sales in Value by Country (2024-2029) & (US$ Million)
Table 45. APAC Human Coagulation Factor VIII Sales in Volume by Country (2018-2023) & (K Bottles)
Table 46. APAC Human Coagulation Factor VIII Sales in Volume by Country (2024-2029) & (K Bottles)
Table 47. Shire (Baxter) Company Information
Table 48. Shire (Baxter) Description and Business Overview
Table 49. Shire (Baxter) Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
Table 50. Shire (Baxter) Human Coagulation Factor VIII Product
Table 51. Shire (Baxter) Recent Development
Table 52. Bayer Company Information
Table 53. Bayer Description and Business Overview
Table 54. Bayer Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
Table 55. Bayer Human Coagulation Factor VIII Product
Table 56. Bayer Recent Development
Table 57. CSL Company Information
Table 58. CSL Description and Business Overview
Table 59. CSL Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
Table 60. CSL Human Coagulation Factor VIII Product
Table 61. CSL Recent Development
Table 62. Pfizer Company Information
Table 63. Pfizer Description and Business Overview
Table 64. Pfizer Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
Table 65. Pfizer Human Coagulation Factor VIII Product
Table 66. Pfizer Recent Development
Table 67. Grifols Company Information
Table 68. Grifols Description and Business Overview
Table 69. Grifols Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
Table 70. Grifols Human Coagulation Factor VIII Product
Table 71. Grifols Recent Development
Table 72. Biogen Company Information
Table 73. Biogen Description and Business Overview
Table 74. Biogen Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
Table 75. Biogen Human Coagulation Factor VIII Product
Table 76. Biogen Recent Development
Table 77. Octapharma Company Information
Table 78. Octapharma Description and Business Overview
Table 79. Octapharma Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
Table 80. Octapharma Human Coagulation Factor VIII Product
Table 81. Octapharma Recent Development
Table 82. NovoNordisk Company Information
Table 83. NovoNordisk Description and Business Overview
Table 84. NovoNordisk Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
Table 85. NovoNordisk Human Coagulation Factor VIII Product
Table 86. NovoNordisk Recent Development
Table 87. Greencross Company Information
Table 88. Greencross Description and Business Overview
Table 89. Greencross Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
Table 90. Greencross Human Coagulation Factor VIII Product
Table 91. Greencross Recent Development
Table 92. Kedrion Company Information
Table 93. Kedrion Description and Business Overview
Table 94. Kedrion Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
Table 95. Kedrion Human Coagulation Factor VIII Product
Table 96. Kedrion Recent Development
Table 97. BPL Company Information
Table 98. BPL Description and Business Overview
Table 99. BPL Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
Table 100. BPL Human Coagulation Factor VIII Product
Table 101. BPL Recent Development
Table 102. Hualan Bio Company Information
Table 103. Hualan Bio Description and Business Overview
Table 104. Hualan Bio Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
Table 105. Hualan Bio Human Coagulation Factor VIII Product
Table 106. Hualan Bio Recent Development
Table 107. RAAS Company Information
Table 108. RAAS Description and Business Overview
Table 109. RAAS Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
Table 110. RAAS Human Coagulation Factor VIII Product
Table 111. RAAS Recent Development
Table 112. Key Raw Materials Lists
Table 113. Raw Materials Key Suppliers Lists
Table 114. Human Coagulation Factor VIII Customers List
Table 115. Human Coagulation Factor VIII Distributors List
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Coagulation Factor VIII Product Picture
Figure 2. Global Human Coagulation Factor VIII Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Human Coagulation Factor VIII Market Size 2018-2029 (US$ Million)
Figure 4. Global Human Coagulation Factor VIII Sales 2018-2029 (K Bottles)
Figure 5. India Human Coagulation Factor VIII Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 6. India Human Coagulation Factor VIII Market Size 2018-2029 (US$ Million)
Figure 7. India Human Coagulation Factor VIII Sales 2018-2029 (K Bottles)
Figure 8. India Human Coagulation Factor VIII Market Share in Global, in Value (US$ Million) 2018-2029
Figure 9. India Human Coagulation Factor VIII Market Share in Global, in Volume (K Bottles) 2018-2029
Figure 10. Human Coagulation Factor VIII Report Years Considered
Figure 11. Product Picture of Recombinant Factor VIII
Figure 12. Product Picture of Plasma-derived Factor VIII
Figure 13. Global Human Coagulation Factor VIII Market Share by Type in 2022 & 2029
Figure 14. Global Human Coagulation Factor VIII Sales in Value by Type (2018-2029) & (US$ Million)
Figure 15. Global Human Coagulation Factor VIII Sales Market Share in Value by Type (2018-2029)
Figure 16. Global Human Coagulation Factor VIII Sales by Type (2018-2029) & (K Bottles)
Figure 17. Global Human Coagulation Factor VIII Sales Market Share in Volume by Type (2018-2029)
Figure 18. Global Human Coagulation Factor VIII Price by Type (2018-2029) & (USD/Bottle)
Figure 19. India Human Coagulation Factor VIII Market Share by Type in 2022 & 2029
Figure 20. India Human Coagulation Factor VIII Sales in Value by Type (2018-2029) & (US$ Million)
Figure 21. India Human Coagulation Factor VIII Sales Market Share in Value by Type (2018-2029)
Figure 22. India Human Coagulation Factor VIII Sales by Type (2018-2029) & (K Bottles)
Figure 23. India Human Coagulation Factor VIII Sales Market Share in Volume by Type (2018-2029)
Figure 24. India Human Coagulation Factor VIII Price by Type (2018-2029) & (USD/Bottle)
Figure 25. Product Picture of Hemophilia A
Figure 26. Product Picture of Spontanous / Trauma
Figure 27. Product Picture of Surgical
Figure 28. Product Picture of Other
Figure 29. Global Human Coagulation Factor VIII Market Share by Application in 2022 & 2029
Figure 30. Global Human Coagulation Factor VIII Sales in Value by Application (2018-2029) & (US$ Million)
Figure 31. Global Human Coagulation Factor VIII Sales Market Share in Value by Application (2018-2029)
Figure 32. Global Human Coagulation Factor VIII Sales by Application (2018-2029) & (K Bottles)
Figure 33. Global Human Coagulation Factor VIII Sales Market Share in Volume by Application (2018-2029)
Figure 34. Global Human Coagulation Factor VIII Price by Application (2018-2029) & (USD/Bottle)
Figure 35. India Human Coagulation Factor VIII Market Share by Application in 2022 & 2029
Figure 36. India Human Coagulation Factor VIII Sales in Value by Application (2018-2029) & (US$ Million)
Figure 37. India Human Coagulation Factor VIII Sales Market Share in Value by Application (2018-2029)
Figure 38. India Human Coagulation Factor VIII Sales by Application (2018-2029) & (K Bottles)
Figure 39. India Human Coagulation Factor VIII Sales Market Share in Volume by Application (2018-2029)
Figure 40. India Human Coagulation Factor VIII Price by Application (2018-2029) & (USD/Bottle)
Figure 41. Americas Human Coagulation Factor VIII Sales in Volume Growth Rate 2018-2029 (K Bottles)
Figure 42. Americas Human Coagulation Factor VIII Sales in Value Growth Rate 2018-2029 (US$ Million)
Figure 43. Americas Human Coagulation Factor VIII Sales by Type (2018-2029) & (K Bottles)
Figure 44. Americas Human Coagulation Factor VIII Sales Market Share in Volume by Type (2018-2029)
Figure 45. Americas Human Coagulation Factor VIII Sales by Application (2018-2029) & (K Bottles)
Figure 46. Americas Human Coagulation Factor VIII Sales Market Share in Volume by Application (2018-2029)
Figure 47. United States Human Coagulation Factor VIII Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 48. Canada Human Coagulation Factor VIII Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 49. Mexico Human Coagulation Factor VIII Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 50. Brazil Human Coagulation Factor VIII Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 51. EMEA Human Coagulation Factor VIII Sales in Volume Growth Rate 2018-2029 (K Bottles)
Figure 52. EMEA Human Coagulation Factor VIII Sales in Value Growth Rate 2018-2029 (US$ Million)
Figure 53. EMEA Human Coagulation Factor VIII Sales by Type (2018-2029) & (K Bottles)
Figure 54. EMEA Human Coagulation Factor VIII Sales Market Share in Volume by Type (2018-2029)
Figure 55. EMEA Human Coagulation Factor VIII Sales by Application (2018-2029) & (K Bottles)
Figure 56. EMEA Human Coagulation Factor VIII Sales Market Share in Volume by Application (2018-2029)
Figure 57. Europe Human Coagulation Factor VIII Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 58. Middle East Human Coagulation Factor VIII Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 59. Africa Human Coagulation Factor VIII Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 60. China Human Coagulation Factor VIII Sales in Volume Growth Rate 2018-2029 (K Bottles)
Figure 61. China Human Coagulation Factor VIII Sales in Value Growth Rate 2018-2029 (US$ Million)
Figure 62. China Human Coagulation Factor VIII Sales by Type (2018-2029) & (K Bottles)
Figure 63. China Human Coagulation Factor VIII Sales Market Share in Volume by Type (2018-2029)
Figure 64. China Human Coagulation Factor VIII Sales by Application (2018-2029) & (K Bottles)
Figure 65. China Human Coagulation Factor VIII Sales Market Share in Volume by Application (2018-2029)
Figure 66. APAC Human Coagulation Factor VIII Sales in Volume Growth Rate 2018-2029 (K Bottles)
Figure 67. APAC Human Coagulation Factor VIII Sales in Value Growth Rate 2018-2029 (US$ Million)
Figure 68. APAC Human Coagulation Factor VIII Sales by Type (2018-2029) & (K Bottles)
Figure 69. APAC Human Coagulation Factor VIII Sales Market Share in Volume by Type (2018-2029)
Figure 70. APAC Human Coagulation Factor VIII Sales by Application (2018-2029) & (K Bottles)
Figure 71. APAC Human Coagulation Factor VIII Sales Market Share in Volume by Application (2018-2029)
Figure 72. Japan Human Coagulation Factor VIII Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 73. South Korea Human Coagulation Factor VIII Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 74. China Taiwan Human Coagulation Factor VIII Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 75. Southeast Asia Human Coagulation Factor VIII Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 76. India Human Coagulation Factor VIII Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 77. Human Coagulation Factor VIII Value Chain
Figure 78. Human Coagulation Factor VIII Production Process
Figure 79. Channels of Distribution
Figure 80. Distributors Profiles
Figure 81. Bottom-up and Top-down Approaches for This Report
Figure 82. Data Triangulation
Figure 83. Key Executives Interviewed
